The best choice depends on the scope of your research and the amount of material required
In its phase 3 TRIUMPH-4 study, the company reported that its new triple-agonist injection, retatrutide, produced an average 28.7% reduction in body weight over 68 weeks a result that surpasses even the blockbuster Zepbound
References Philippou, A., Maridaki, M., Halapas, A., & Koutsilieris, M
A strong case usually includes BMI data, related health risks, lifestyle efforts, a follow-up plan, and a clear reason the selected medication fits the patients goals and safety needs
Plateaus are nearly universal in weight loss journeys, as the body adapts to protect its energy reserves
For quantitative synthesis, effect estimates were collected when available, including HRs, 95% CI, and associated p-values